Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elevated C1s/C1-INH in serum and plasma of myasthenia gravis patients. | J Neuroimmunol | 2024 | 39255718 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies venous thromboembolism-related genes F3, PLAT, and C1S as potential prognostic biomarkers for glioblastoma and lower grade glioma. | Mol Biomed | 2024 | 39179711 | PubTator, text mining | PubMed |
| The Establishment of Complement System Is from Gene Duplication and Domain Shuffling. | Int J Mol Sci | 2024 | 39125697 | PubTator, text mining | PubMed |
| Causal relationship between complement C1QB and colorectal cancer: a drug target Mendelian randomization study. | Front Genet | 2024 | 39109334 | PubTator, text mining | PubMed |
| Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B. | EClinicalMedicine | 2024 | 39091672 | PubTator, text mining | PubMed |
| A novel missense variant in CAT gene causing acatalasemia with gangrenous periodontitis (Takahara's disease). | Arch Oral Biol | 2024 | 39079473 | PubTator, text mining | PubMed |
| The expression and biological role of complement C1s in esophageal squamous cell carcinoma. | Open Life Sci | 2024 | 39071493 | PubTator, text mining | PubMed |
| sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID. | iScience | 2024 | 39027374 | PubTator, text mining | PubMed |
| The Crystal Structure of the Michaelis-Menten Complex of C1 Esterase Inhibitor and C1s Reveals Novel Insights into Complement Regulation. | J Immunol | 2024 | 38995166 | PubTator, text mining | PubMed |
| [Cold agglutinin disease: pathology, diagnosis, and treatment]. | Rinsho Ketsueki | 2024 | 38960651 | PubTator, text mining | PubMed |
| C1s targeting antibodies inhibit the growth of cutaneous squamous carcinoma cells. | Sci Rep | 2024 | 38866870 | PubTator, text mining | PubMed |
| Unraveling breast cancer prognosis: a novel model based on coagulation-related genes. | Front Mol Biosci | 2024 | 38751445 | PubTator, text mining | PubMed |
| Detection of genetic mutations underlying early-onset systemic lupus erythematosus. | Lupus | 2024 | 38739464 | PubTator, text mining | PubMed |
| Exploration of the influence of GOLGA8B on prostate cancer progression and the resistance of castration-resistant prostate cancer to cabazitaxel. | Discov Oncol | 2024 | 38730195 | PubTator, text mining | PubMed |
| Monocytes: See One Queuing Local Adaptive Immune Responses to Respiratory Viruses. | Am J Respir Cell Mol Biol | 2024 | 38717817 | PubTator, text mining | PubMed |
| Identification of key eRNAs for intervertebral disc degeneration by integrated multinomial bioinformatics analysis. | BMC Musculoskelet Disord | 2024 | 38704519 | PubTator, text mining | PubMed |
| [Dynamic trajectory and cell communication of different cell clusters in malignant progression of glioblastoma]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2024 | 38595234 | PubTator, text mining | PubMed |
| Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression. | Oncoimmunology | 2024 | 38487624 | PubTator, text mining | PubMed |
| Could signal peptide complement C1r/C1s, Uegf, and Bmp1, and epidermal growth factor-containing protein 1 be a therapeutic target in the pathogenesis of preeclampsia? | Rev Assoc Med Bras (1992) | 2024 | 38451587 | PubTator, text mining | PubMed |
| Disrupted Tuzzerella abundance and impaired L-glutamine levels induce Treg accumulation in ovarian endometriosis: a comprehensive multi-omics analysis. | Metabolomics | 2024 | 38424274 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=8